Product Code: ETC13182295 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Plasma Protein Therapeutics Market was valued at USD 32 Billion in 2024 and is expected to reach USD 46 Billion by 2031, growing at a compound annual growth rate of 5.30% during the forecast period (2025-2031).
The Global Plasma Protein Therapeutics Market is a rapidly growing sector driven by increasing demand for plasma-derived therapies to treat a variety of rare and chronic diseases. With advancements in biotechnology and increasing investment in research and development, the market is witnessing significant expansion. Key factors contributing to the market growth include rising prevalence of immune deficiencies, hemophilia, and other rare diseases, coupled with an aging population. Additionally, the expanding applications of plasma protein therapies in neurology, hematology, and immunology further propel market growth. The market is characterized by key players such as CSL Behring, Grifols, Takeda Pharmaceutical Company, and Octapharma AG, among others, who are continuously innovating and launching new products to meet the growing demand for plasma protein therapeutics worldwide.
The Global Plasma Protein Therapeutics Market is experiencing significant growth driven by the increasing prevalence of chronic diseases, technological advancements in plasma fractionation, and the rising demand for immunoglobulins and clotting factors. The market is witnessing a shift towards personalized medicine and the development of novel therapies such as gene therapy and regenerative medicine. Opportunities exist in emerging markets due to improving healthcare infrastructure and growing awareness about plasma protein therapies. Additionally, the rise in research and development activities, strategic collaborations, and acquisitions by key players are expected to drive market expansion. However, challenges such as stringent regulations and high costs associated with plasma protein therapies may hinder market growth. Overall, the market presents promising prospects for innovation and investment in the coming years.
The Global Plasma Protein Therapeutics Market faces several challenges, including regulatory hurdles related to product approval and manufacturing processes, increasing competition from alternative treatment options such as gene therapy and biosimilars, and pricing pressures due to the high cost of plasma-derived products. Additionally, supply chain disruptions and fluctuations in plasma donation levels can impact the availability of these life-saving therapies. Moreover, the industry also grapples with the risk of infectious disease transmission through plasma products and the need for stringent quality control measures. Keeping up with technological advancements and addressing ethical concerns related to plasma donation and usage further add complexity to the market landscape, requiring continuous innovation and strategic planning by companies operating in this sector.
The Global Plasma Protein Therapeutics Market is primarily driven by increasing prevalence of rare diseases and chronic conditions such as hemophilia, immune deficiencies, and neurological disorders which require plasma protein therapies for treatment. Additionally, advancements in biotechnology and medical research have led to the development of more effective and targeted plasma protein therapies, driving market growth. Rising healthcare expenditure, improving healthcare infrastructure in developing countries, and growing awareness about the benefits of plasma protein therapies among healthcare professionals and patients are also contributing to the market expansion. Moreover, the increasing geriatric population worldwide, who are more susceptible to conditions that require plasma protein therapies, is further boosting market demand. Overall, these factors are driving the growth of the Global Plasma Protein Therapeutics Market.
Government policies related to the Global Plasma Protein Therapeutics Market vary by country but generally focus on ensuring the safety and quality of plasma-derived products, regulating pricing and reimbursement, and promoting self-sufficiency in plasma collection. In the United States, the FDA oversees the approval and regulation of plasma protein therapies, while reimbursement policies set by Medicare and Medicaid impact patient access. In Europe, the European Medicines Agency (EMA) plays a similar role in product approval, and various member states have implemented policies to encourage domestic plasma collection to reduce reliance on imports. Overall, government policies aim to balance patient access to essential therapies with ensuring product safety, quality, and affordability in the Global Plasma Protein Therapeutics Market.
The Global Plasma Protein Therapeutics Market is expected to witness steady growth in the coming years, driven by factors such as the increasing prevalence of chronic diseases, rising geriatric population, and expanding applications of plasma protein therapies. Technological advancements in plasma fractionation techniques and the development of novel therapies are also anticipated to contribute to market growth. Moreover, the growing awareness about the benefits of plasma protein therapeutics, coupled with improving healthcare infrastructure in emerging economies, is likely to further propel market expansion. However, challenges such as regulatory hurdles and high production costs may hinder market growth to some extent. Overall, the Global Plasma Protein Therapeutics Market is projected to experience continued growth, offering opportunities for market players to innovate and expand their product offerings.
In the Global Plasma Protein Therapeutics Market, Asia is experiencing rapid growth due to increasing healthcare expenditure and rising prevalence of chronic diseases. North America dominates the market with a strong presence of key players, advanced healthcare infrastructure, and high demand for plasma protein therapeutics. Europe follows closely with a mature market, stringent regulatory framework, and growing focus on research and development. The Middle East and Africa region is witnessing steady growth driven by improving healthcare infrastructure and rising awareness about plasma protein therapies. Latin America is also showing promising growth prospects due to expanding healthcare access and increasing investments in healthcare facilities. Overall, the global plasma protein therapeutics market is expected to continue its growth trajectory across all regions, driven by increasing patient population and advancements in medical technologies.
Global Plasma Protein Therapeutics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Plasma Protein Therapeutics Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Plasma Protein Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Global Plasma Protein Therapeutics Market - Industry Life Cycle |
3.4 Global Plasma Protein Therapeutics Market - Porter's Five Forces |
3.5 Global Plasma Protein Therapeutics Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Plasma Protein Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Plasma Protein Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Plasma Protein Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Plasma Protein Therapeutics Market Trends |
6 Global Plasma Protein Therapeutics Market, 2021 - 2031 |
6.1 Global Plasma Protein Therapeutics Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Plasma Protein Therapeutics Market, Revenues & Volume, By Albumin, 2021 - 2031 |
6.1.3 Global Plasma Protein Therapeutics Market, Revenues & Volume, By Immunoglobulin, 2021 - 2031 |
6.1.4 Global Plasma Protein Therapeutics Market, Revenues & Volume, By Plasma-derived Factor VIII, 2021 - 2031 |
6.1.5 Global Plasma Protein Therapeutics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Plasma Protein Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Plasma Protein Therapeutics Market, Revenues & Volume, By Hemophilia, 2021 - 2031 |
6.2.3 Global Plasma Protein Therapeutics Market, Revenues & Volume, By Primary Immunodeficiency Disorder (PIDD), 2021 - 2031 |
6.2.4 Global Plasma Protein Therapeutics Market, Revenues & Volume, By Idiopathic Thrombocytopenic Purpura (ITP), 2021 - 2031 |
6.2.5 Global Plasma Protein Therapeutics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Plasma Protein Therapeutics Market, Overview & Analysis |
7.1 North America Plasma Protein Therapeutics Market Revenues & Volume, 2021 - 2031 |
7.2 North America Plasma Protein Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Plasma Protein Therapeutics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Plasma Protein Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Plasma Protein Therapeutics Market, Overview & Analysis |
8.1 Latin America (LATAM) Plasma Protein Therapeutics Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Plasma Protein Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Plasma Protein Therapeutics Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Plasma Protein Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Plasma Protein Therapeutics Market, Overview & Analysis |
9.1 Asia Plasma Protein Therapeutics Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Plasma Protein Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Plasma Protein Therapeutics Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Plasma Protein Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Plasma Protein Therapeutics Market, Overview & Analysis |
10.1 Africa Plasma Protein Therapeutics Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Plasma Protein Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Plasma Protein Therapeutics Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Plasma Protein Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Plasma Protein Therapeutics Market, Overview & Analysis |
11.1 Europe Plasma Protein Therapeutics Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Plasma Protein Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Plasma Protein Therapeutics Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Plasma Protein Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Plasma Protein Therapeutics Market, Overview & Analysis |
12.1 Middle East Plasma Protein Therapeutics Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Plasma Protein Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Plasma Protein Therapeutics Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Plasma Protein Therapeutics Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Plasma Protein Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Plasma Protein Therapeutics Market Key Performance Indicators |
14 Global Plasma Protein Therapeutics Market - Export/Import By Countries Assessment |
15 Global Plasma Protein Therapeutics Market - Opportunity Assessment |
15.1 Global Plasma Protein Therapeutics Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Plasma Protein Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Plasma Protein Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Plasma Protein Therapeutics Market - Competitive Landscape |
16.1 Global Plasma Protein Therapeutics Market Revenue Share, By Companies, 2024 |
16.2 Global Plasma Protein Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |